中国创新药企初具全球竞争力,它们有哪些成功经验可供后来者借鉴? 百济神州与信达生物先后成立于2010年和2011年,两者都已经有创新药上市,是中国制药产业的代表性企业。但两家企业所走的道路完全不同。百济神州起步就是创新药和全球化,信达生物则先在本土稳扎稳打,然后才谋划国际市场。 近日,信达生物首席研发官钱镭在一场论坛上表示,百济神州是特定时期发展起来的企业,其成长路径缺乏可复制性。百济神州...
Source Link中国创新药企初具全球竞争力,它们有哪些成功经验可供后来者借鉴? 百济神州与信达生物先后成立于2010年和2011年,两者都已经有创新药上市,是中国制药产业的代表性企业。但两家企业所走的道路完全不同。百济神州起步就是创新药和全球化,信达生物则先在本土稳扎稳打,然后才谋划国际市场。 近日,信达生物首席研发官钱镭在一场论坛上表示,百济神州是特定时期发展起来的企业,其成长路径缺乏可复制性。百济神州...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.